Thyrocare Technologies Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Thyrocare Technologies Limited generated cash of $1,676,300,000, which is more than the previous year. Cash used in financing activities reached the amount of -$848,100,000 last year. Net change in cash is therefore -$84,700,000.
Cash Flow
| 2016 | 678.01M | -176.75M | -449.56M |
|---|---|---|---|
| 2018 | 1.07B | -432.19M | -638.76M |
| 2020 | 1.67B | 9.5M | -1.64B |
| 2021 | 1.16B | -502.3M | -615.7M |
| 2023 | 1.29B | -389.9M | -861.8M |
| 2024 | 1.67B | -912.8M | -848.1M |
THYROCARE.NS Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 177.7M | 136.3M | 89.6M | 49.1M | 98.84M | 50.75M |
Operating activities | ||||||
Net income | 707.6M | 874.1M | 1.52B | 1.46B | 1.44B | 818.03M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 470.1M | 387.1M | 302.8M | 319.1M | 201M | 182.37M |
Stock-based compensation expense | 166.7M | 211.7M | 16.8M | 20M | 17.1M | 17.73M |
| Deferred income tax benefit | 166.7M | 211.7M | 16.8M | 20M | 17.1M | 17.73M |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 328.2M | -14.3M | -285.6M | -60.3M | -37.13M | -24.67M |
Inventories | -198.5M | -31.4M | -27.4M | -25.4M | -25.56M | -33.51M |
Accounts payable | 161.2M | 74.2M | 31.5M | 143.5M | -1.33M | 12.11M |
Cash generated by operating activities | 1.67B | 1.29B | 1.16B | 1.67B | 1.07B | 678.01M |
Investing activities | ||||||
Purchases Of Investments | -278.8M | -1.92B | -1.36B | -1.33B | -914.27M | -1.06B |
Investments In Property Plant And Equipment | -615.8M | -436.5M | -282.6M | -99M | -436.5M | -144.2M |
Acquisitions Net | 0 | 34M | 42.5M | -95.9M | -100M | 750K |
Cash generated by investing activities | -912.8M | -389.9M | -502.3M | 9.5M | -432.19M | -176.75M |
Financing activities | ||||||
Common Stock Issued | 200K | 300K | 300K | 400K | 0 | 0 |
Payments for dividends | -952.7M | -793.5M | -528.4M | -1.59B | -537.24M | -379.02M |
Repurchases of common stock | 0 | 0 | 24.8M | 0 | 0 | 0 |
Repayments of term debt | 215.9M | 0 | -25M | 0 | 0 | 0 |
Cash used in financing activities | -848.1M | -861.8M | -615.7M | -1.64B | -638.76M | -449.56M |
Net Change In Cash | -84.7M | 41.4M | 42.4M | 38M | -640K | 51.7M |
Cash at end of period | 93M | 177.7M | 132M | 87.1M | 98.2M | 102.45M |
| Data source | Data source | Data source | Data source | Data source | Data source |